Launch of Phase 2 of the Optimal CAB

Significant progress has been made over the past decade to increase access to HIV care for all people living with HIV (PLHIV). However, despite these gains, challenges still persist in making the latest optimal treatments rapidly available for all populations in low-and-middle income countries (LMICs). Through the Optimal Project, Unitaid and CHAI have worked closely to help accelerate the development and introduction of new, optimal ARVs and diagnostic and treatment products for Advanced HIV Disease. An important part of these efforts has been the role of the community, whose work to increase treatment literacy among PLHIV, generate demand for the best treatments, and advocate for vulnerable populations on national and global stages has helped ensure patients have access to the best available products. As the Optimal Project begins its second phase, the role of the community remains an important part of the project.

Phase 2 of the Optimal Project aims to increase demand for target ARV and AHD products in focal countries, driving rapid uptake and lowering global costs. The Optimal CAB will support the project by:
 Strengthening community engagement in product adoption to ensure smooth transition and rollout of new products
 Fostering demand generation and treatment literacy of ARV and AHD commodities
 Ensuring that the patient voice is at the center of national and global decision-making

Published: March 24, 2021
Last edited: March 24, 2021